肯塔基州 的 急性髓系白血病 临床试验
肯塔基州 有 14 项针对 急性髓系白血病 的研究正在招募参与者。
肯塔基州 的城市
官方研究文本(英文)
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
- University of Kentucky/Markey Cancer Center, Lexington
- The James Graham Brown Cancer Center at University of Louisville, Louisville
- UofL Health Medical Center Northeast, Louisville
招募中2 期
18 至 59 岁 · 所有性别 · 更新于 2026年9月28日 · NCT05554393A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
- University of Kentucky Markey Cancer Center, Lexington
- UofL Health Brown Cancer Center, Louisville
- Norton Cancer Institute, Louisville
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月25日 · NCT06852222MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
- University of Kentucky/Markey Cancer Center, Lexington
- The James Graham Brown Cancer Center at University of Louisville, Louisville
- UofL Health Medical Center Northeast, Louisville
招募中2 期
18 岁及以上 · 所有性别 · 更新于 2026年9月25日 · NCT05564390Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
- The James Graham Brown Cancer Center at University of Louisville, Louisville
- UofL Health Medical Center Northeast, Louisville
招募中2 期
18 岁及以上 · 所有性别 · 更新于 2026年9月22日 · NCT06672146Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
- University of Kentucky/Markey Cancer Center, Lexington
- The James Graham Brown Cancer Center at University of Louisville, Louisville
- UofL Health Medical Center Northeast, Louisville
招募中2 期
18 岁及以上 · 所有性别 · 更新于 2026年9月22日 · NCT06317649Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
- University of Kentucky/Markey Cancer Center, Lexington
- The James Graham Brown Cancer Center at University of Louisville, Louisville
- UofL Health Medical Center Northeast, Louisville
招募中2 期
18 至 59 岁 · 所有性别 · 更新于 2026年9月22日 · NCT05554406A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
- University of Kentucky/Markey Cancer Center, Lexington
- Norton Children's Hospital, Louisville
招募中3 期
6 Months – 21 Years · 所有性别 · 更新于 2026年9月17日 · NCT04293562Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
- University of Kentucky/Markey Cancer Center, Lexington
- Norton Children's Hospital, Louisville
招募中3 期
1 至 25 岁 · 所有性别 · 更新于 2026年9月4日 · NCT07022678Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- CommonSpirit Saint Joseph Hospital - Bardstown, Bardstown
- Commonwealth Cancer Center-Corbin, Corbin
- Saint Elizabeth Healthcare Edgewood, Edgewood
- 以及另外 5 项
招募中观察性研究欢迎健康志愿者
40 至 75 岁 · 所有性别 · 更新于 2026年9月2日 · NCT05334069The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- University of Kentucky/Markey Cancer Center, Lexington
- Norton Children's Hospital, Louisville
招募中1/2 期
22 岁及以下 · 所有性别 · 更新于 2026年8月25日 · NCT04726241Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
- Norton Children's Hospital, Louisville
招募中3 期
29 Days – 21 Years · 所有性别 · 更新于 2026年8月24日 · NCT05183035Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
- University of Kentucky, Lexington
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年8月20日 · NCT07007312A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- University of Louisville Hospital - James Brown Cancer Center, Louisville
招募中观察性研究
所有年龄段 · 所有性别 · 更新于 2026年7月6日 · NCT01351545A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
- University of Kentucky Markey Cancer Center, Louisville
- Norton Cancer Institute - St. Matthews, Louisville
招募中1 期
18 岁及以上 · 所有性别 · 更新于 2026年3月13日 · NCT05735184数据来自 ClinicalTrials.gov,检索日期:2026年10月1日。每项研究自行设定入选标准,由研究团队决定谁能参与。